New aspects of non-alcoholic fatty liver disease by V. V. Tsukanov, E. V. Kasparov, Yu. L. Tonkikh, A. V. Vasyutin

“…To analyze modern data on pathogenesis and principles of treatment of non-alcoholic fatty liver disease (NAFLD).Key points. Now concepts on genetic determinants of NAFLD and diagnostics methods develop rapidly. …”
Get full text

Improvement of non-alcoholic fatty liver disease treatment by P. I. Seliverstov, V. G. Radchenko

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Options of dyslipidemia treatment at non-alcoholic fatty liver disease by M. V. Mayevskaya, M. A. Morozova

“…To consider different treatment options for dyslipidemia in non-alcoholic fatty liver disease (NAFLD). Summary. NAFLD occurs in 20-30% of adult population. …”
Get full text

Epidemiologic features of non-alcoholic fatty liver disease in Russia by O. M. Drapkina, V. T. Ivashkin

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia by Masahiro Kikuchi, Miho Kikuchi, Masahiro Konishi

Subjects: Get full text

Pathogenic role of lipids in non-alcoholic fatty liver disease by Yu. O. Shulpekova

Subjects: Get full text

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease by N. V. Bivalkevich, Yu. K. Denisenko, T. P. Novgorodtseva

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease by M. V. Mayevskaya, V. T. Ivashkin

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity by I. V. Logacheva, T. A. Ryazanova, V. R. Makarova, O. V. Surnina

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota by R. V. Maslennikov, Yu. V. Evsyutina

Subjects: Get full text

Peran Antioksidan pada Non Alcoholic Fatty Liver Disease (NAFLD) by Yusri Diane Jurnalis, Yorva Sayoeti, Elfitrimelly .

Get full text

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease by Roger F. Butterworth, Ali Canbay

Subjects: Get full text

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran by Amin Ghanbari, Mohammadreza Pazoki, Bahar Allahverdi, Pejman Rohani, Parisa Rahmani

Subjects: “…non-alcoholic fatty liver disease (nafld)…”
Get full text

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease by O. Yu. Kytikova, T. P. Novgorodtseva, Yu. K. Denisenko, D. A. Kovalevsky

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease by Emmanouil Nychas, Andrea Marfil-Sánchez, Xiuqiang Chen, Mohammad Mirhakkak, Huating Li, Weiping Jia, Aimin Xu, Henrik Bjørn Nielsen, Max Nieuwdorp, Rohit Loomba, Yueqiong Ni, Gianni Panagiotou

“…Abstract Background The pathogenesis of non-alcoholic fatty liver disease (NAFLD) with a global prevalence of 30% is multifactorial and the involvement of gut bacteria has been recently proposed. …”
Get full text

Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease by Swati U. Chavan, Pravin Rathi, Ameet Mandot

Get full text

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment by Ye. N. Shirokova

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease by Sun Xin, Zhang Yan, Xie Meilin

Subjects: “…non alcoholic fatty liver disease…”
Get full text

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus by A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study by Steven Dooley, Juan Du, Xiaoping Tang, Lan Chen, Jinzhu Jia, Fujun Li, Yanyan Shi, Christoph Meyer, Zhongwei Zhu, Yanming Zhang, Roman Liebe, Keming Hu, Tingting Zhou, Huier Zhang, Hong-Lei Weng, Tong Huang

“…Objectives To clarify non-alcoholic fatty liver disease (NAFLD) prevalence, risk factors and clinical outcome in an exemplary Chinese population, a cohort of company employees was followed up for 11 years.Design Retrospective cohort study.Setting Between 2006 and 2016 in Ning bo, China.Participants 13 032 company employees.Results Over 11 years, the prevalence of NAFLD increased from 17.2% to 32.4% (men 20.5%–37% vs women 9.8%–22.2%). …”
Get full text